Peak Flow Meters
Customize your policy alerts
Sign up for Aetna Policy 0059 alerts
Get alerted when Policy 0059 changes without checking for updates manually.
Monitor payer policy activity
This policy governs coverage and medical necessity determinations for peak flow meters and spacers as durable medical equipment for Aetna members with asthma and other obstructive pulmonary conditions, and describes exclusion of electronic peak flow meters. It affects providers ordering or billing for these devices.
No material clinical or coverage changes in this revision.
Coverage Criteria for Peak Flow Meters and Spacers
Medical necessity - standard mechanical devices
Covered when ALL of the following are met
Supports coverage of HCPCS/S codes when selection criteria are met
Experimental / Investigational - electronic peak flow meters
Not covered / experimental when the following apply
Leads to noncoverage of electronic devices
Peak flow meters are intended for monitoring airway obstruction but should not be used to diagnose chronic obstructive pulmonary disease (COPD). This exclusion is stated explicitly in the policy and aligns with clinical guidance that peak flow measurements are not diagnostic for COPD.
Electronic peak expiratory flow rate systems (for example, the AirWatch System and the PeakLog Peak Flow Chronologger) are considered unproven and not medically necessary for management of asthma, COPD, or other expiratory diseases because available evidence does not demonstrate clinically significant advantages over standard mechanical peak flow meters.
Reported benefits of electronic systems — such as automatic data storage, transmission, graphical display, and measurement of FEV‑1 in addition to PEFR — have not been shown to improve patient compliance, clinical management, or outcomes compared with standard devices. Therefore requests for electronic peak flow meters are treated as experimental/investigational and not covered.
Billing and Coding
| A4614 | Peak expiratory flow rate meter, hand held. |
| A4627 | Spacer, bag or reservoir, with or without mask, for use with metered dose inhaler. |
| S8096 | Portable peak flow meter. |
| S8097 | Asthma kit (including but not limited to portable peak expiratory flow meter, instructional video, brochure, and/or spacer). |
| S8100 | Holding chamber or spacer for use with an inhaler or nebulizer; without mask. |
| S8101 | Holding chamber or spacer for use with an inhaler or nebulizer; with mask. |
| S8110 | Peak expiratory flow rate (physician services). |
| J20.0 - J21.9 | Acute bronchitis and acute bronchiolitis. |
| J40 - J47.9 | Chronic lower respiratory diseases. |
| J67.0 - J67.9 | Hypersensitivity pneumonitis due to organic dust |
Provider Actions, Documentation, and Denial Risk
DME codes covered when medical necessity met
Certain HCPCS/S codes for peak flow meters, spacers, and asthma kits are covered when medical necessity (member has asthma, bronchitis, emphysema, or other obstructive pulmonary condition) is documented on the prescription/order. Providers should supply diagnoses and clinical indication when requesting or billing DME. Electronic peak flow meters are considered experimental/investigational and will be denied.
- DME covered when medical necessity met: A4614, A4627, S8096, S8097, S8100, S8101, S8110 (see ICD-10 codes below).
- Documented clinical indication required: asthma, bronchitis, emphysema, or other obstructive pulmonary condition on prescription/order.
- Electronic peak flow meters (e.g., PeakLog, AirWatch and similar devices) are considered experimental/investigational and will be denied.
Device selection preference
There is no step therapy requirement; standard mechanical peak flow meters and spacers are the first-line covered devices. Electronic systems are unproven and not covered.
Clinical indication documentation
Prescriptions, orders, and prior authorization requests must state the member's relevant diagnosis (asthma, bronchitis, emphysema, or other obstructive pulmonary condition). Include clinical justification that the device is for home monitoring of an obstructive pulmonary condition. Peak flow meters should not be used to diagnose COPD.
- Include ICD-10 diagnosis codes corresponding to acute or chronic lower respiratory disease (e.g., J20–J21, J40–J47, J67).
- Document clinical reason for device and how it will be used in management (monitoring control, guiding therapy, patient education).
Electronic peak flow meters - denial risk
Requests for electronic peak flow meters will be denied as experimental/investigational due to inadequate evidence of clinical benefit compared to standard mechanical peak flow meters.
- Do not submit electronic peak flow meter requests unless supporting peer-reviewed evidence demonstrating superior clinical outcomes is provided.
- If electronic monitoring is requested, include documentation showing medical necessity that cannot be met with a standard mechanical device.
Background and Clinical Context
Peak flow meters are commonly prescribed to monitor asthma, COPD, and other respiratory diseases to assess disease severity and response to therapy at home. Standard devices are handheld mechanical meters (spring‑loaded vane or piston) that measure peak expiratory flow (PEFR) and are considered medically necessary durable medical equipment for members with asthma, bronchitis, emphysema, or other obstructive pulmonary conditions.
Electronic peak flow systems can store and transmit PEFR and may also report FEV‑1, and they provide conveniences such as automated recording and graphical displays. However, the policy finds inadequate evidence that these electronic systems produce superior health outcomes or meaningful clinical advantages over standard mechanical peak flow meters.
Because of these limitations, the policy maintains coverage for standard mechanical peak flow meters and spacers when medical necessity criteria are met, while electronic peak flow meters remain classified as experimental/investigational and are not covered.
Definitions
Policy Revision History
Policy became effective.
Policy was reviewed (last review date recorded).
Next scheduled policy review date.
Policy history entry reflecting last review recorded on this date.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.